북미 심장 모니터링 및 심장 리듬 관리 장치 시장 – 2030년까지의 산업 동향 및 예측

북미 심장 모니터링 및 심장 리듬 관리 장치 시장 분석 및 규모

북미 심장 모니터링 및 심장 리듬 관리 장치 시장은 다양한 요인으로 인해 상당한 성장을 경험하고 있습니다. 심혈관 질환의 유병률 증가, 인구 고령화 증가, 의료 기술의 발전으로 인해 이 지역에서 심장 모니터링 및 리듬 관리 장치에 대한 수요가 증가하고 있습니다. 또한, 심장 상태의 조기 발견 및 관리에 대한 인식이 높아지고 유리한 환불 정책이 결합되어 시장 확장이 촉진되고 있습니다.                                

Data Bridge Market Research는 2022년에 2,245.87백만 달러였던 심장 모니터링 및 심장 리듬 관리 장치 시장이 2030년까지 3,567.57백만 달러로 급증할 것이며 예측 기간 동안 3.90%의 CAGR을 경험할 것으로 분석했습니다. 이는 시장 가치를 나타냅니다. "ECG 장치"는 심장 리듬 모니터링을 위한 ECG 장치에 대한 수요가 증가함에 따라 심장 모니터링 및 심장 리듬 관리 장치 시장의 제품 부문을 지배하고 있습니다. 시장 가치, 성장률, 세분화, 지리적 범위 및 주요 업체와 같은 시장 시나리오에 대한 통찰력 외에도 Data Bridge Market Research에서 큐레이팅한 시장 보고서에는 심층 전문가 분석, 환자 역학, 파이프라인 분석, 가격 분석 및 규제 프레임워크도 포함됩니다.

북미 심장 모니터링 및 심장 리듬 관리 장치 시장 범위 및 세분화

시장 정의

카디아 모니터는 스트레스 파형 형태의 심장의 전기적 운동을 반영하는 하드웨어로 정의됩니다. 심전도를 통해 코어의 꾸준하고 일시적인 운동을 추적합니다. 코어의 부드럽고 적절한 기능을 위해 코어 챔버 내부에 배치됩니다. 이러한 장치는 심방 잡음, 최근 심장 파업 징후, 심방 세동, 심부전 , 관상 허혈, 심장 조직에 대한 산소 가용성 부족, 약물 영향 및 특정 유전적 실수와 같은 주요 심장 질환을 치료하는 데 사용됩니다.            

북미 심장 모니터링 및 심장 리듬 관리 장치 시장 역학

운전자

• 심혈관 질환의 유병률 증가

심부전, 부정맥, 관상 동맥 질환을 포함한 심혈관 질환의 증가는 심장 모니터링 및 심장 리듬 관리 장치 시장의 주요 원동력입니다. 증가하는 노령 인구, 앉아서 보내는 생활 방식, 건강에 해로운 식습관은 심혈관 질환의 부담을 증가시켜 모니터링 및 관리 장치에 대한 수요가 높아지고 있습니다.

• 심장 건강에 대한 인식 제고 및 사전 예방적 접근 방식

개인들은 심장 질환의 조기 발견과 사전 관리의 중요성을 점점 더 인식하고 있습니다. 사람들은 심장 건강을 유지하는 것에 대해 더욱 의식하고 있으며 예방 조치와 정기적인 모니터링을 추구하고 있습니다. 소비자 행동의 이러한 변화는 심장 모니터링 장치와 리듬 관리 솔루션에 대한 수요를 촉진합니다.

기회

• 홈 기반 및 원격 모니터링 솔루션에 대한 수요 증가

심장 모니터링 및 심장 리듬 관리 장치 시장에서는 홈 기반 및 원격 모니터링 솔루션에 대한 추세가 커지고 있습니다. 환자와 의료 서비스 제공자는 집에서 편안하게 심장 건강을 모니터링하는 것의 이점을 점점 더 인식하고 있습니다. 이는 기업이 사용자 친화적이고 휴대 가능하며 실시간 데이터를 의료 전문가에게 전송할 수 있는 장치를 개발하고 마케팅하여 심장 상태를 사전에 관리할 수 있는 기회를 제공합니다.

• Integration of artificial intelligence (AI) and machine learning (ML)

The integration of AI and ML algorithms in cardiac monitoring and rhythm management devices offers significant opportunities for the market. These technologies can analyze large volumes of patient data, identify patterns, and provide predictive analytics for early detection of cardiac abnormalities. AI-driven algorithms can also assist in personalized treatment recommendations and decision-making, improving patient outcomes. Companies that leverage AI and ML capabilities to enhance the accuracy and efficiency of cardiac monitoring and rhythm management devices have a competitive advantage in the market.

Restraints

• High cost of devices and limited healthcare budgets

The cost of cardiac monitoring and cardiac rhythm management devices can be significant, especially for advanced and innovative technologies. This high cost may pose a restraint to market growth, particularly in regions with limited healthcare budgets. Healthcare providers and patients may face challenges in accessing and affording these devices, impacting their adoption rates and overall market expansion.

• Stringent regulatory requirements

The cardiac monitoring and cardiac rhythm management devices market is subject to stringent regulatory requirements, including product approvals and certifications. Obtaining regulatory approvals can be time-consuming and costly, which can hinder the introduction of new devices into the market. Compliance with regulatory standards, such as those set by the FDA in the United States, requires rigorous testing and documentation, which can pose challenges for smaller manufacturers or companies with limited resources.

Challenges

• Intense competition and market saturation

The cardiac monitoring and cardiac rhythm management devices market is highly competitive, with numerous companies vying for market share. This intense competition can make it challenging for new entrants to establish a foothold and for existing players to maintain their market position. The market may also become saturated with similar products, leading to price pressures and reduced profit margins for companies.

• Data privacy and security concerns

Cardiac monitoring and rhythm management devices generate a vast amount of sensitive patient data. Ensuring the privacy and security of this data is a significant challenge for the market. Healthcare organizations and device manufacturers need to implement robust data protection measures to prevent unauthorized access, breaches, and potential misuse of patient information. Compliance with data privacy regulations, such as HIPAA in the United States, adds an additional layer of complexity and responsibility.

This cardiac monitoring and cardiac rhythm management devices market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the cardiac monitoring and cardiac rhythm management devices market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Developments

• In November 2022, Boston Scientific the LUX-Dx Insertable Cardiac Monitor (ICM) System, a long-term diagnostic device inserted under the skin of patients to detect arrhythmias associated with conditions such as atrial fibrillation (AF), cryptogenic stroke, and syncope in Europe.
• In October 2022, Medtronic PLC received the United States FDA approval for extended labeling of a cardiac lead that uses the heart's natural electrical system to deliver therapy to patients while avoiding complications.

North America Cardiac Monitoring and Cardiac Rhythm Management Devices Market Scope

The cardiac monitoring and cardiac rhythm management devices market is segmented on the basis of product and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product

• ECG devices

Type

• Resting ECG systems
• Stress ECG systems
• Holter monitors

Lead type

• Single-lead ECG leadwires
• ECG leadwires
• Others
• Implantable loop recorders
• Cardiac output monitoring (COM) devices
• Minimally invasive COM devices
• Noninvasive COM devices
• Event monitors

Type

• Pre-symptom (Memory Loop)
• Post-symptom event monitor

Technology

• Auto detect monitors
• Manual event monitor
• Mobile cardiac telemetry monitoring (MCT/MCOT)
• Smart wearable ECG monitors
• Defibrillators

Implantable cardioverter defibrillators

• Transvenous implantable cardioverter defibrillators
• Biventricular ICDS/cardiac resynchronization therapy defibrillators
• Dual-chamber ICDS
• Single-chamber ICDS
• Subcutaneous implantable cardioverter defibrillators

External defibrillators

• Automated external defibrillators
• Fully automated external defibrillators
• Semi-automated external defibrillators
• Pacemakers

Type

• Dual-chamber pacemakers
• Single-chamber pacemakers
• Implantability
• Implantable pacemakers
• External pacemakers
• Cardiac resynchronization therapy (CRT) devices
• CRT-P (CRT with pacemaker function)
• CRT-D (CRT with pacemaker and ICD function)

End-User

• Hospitals
• Home and ambulatory care settings
• Others

North America Cardiac Monitoring and Cardiac Rhythm Management Devices Market Regional Analysis/Insights

The cardiac monitoring and cardiac rhythm management devices market is analysed, and market size insights and trends are provided by country, product and end-user, as referenced above.

The countries covered in the cardiac monitoring and cardiac rhythm management devices market report are U.S., Canada and Mexico in North America.

The U.S. is expected to dominate North America cardiac monitoring and cardiac rhythm management devices market due to Technical advancement in the field of cardiac.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, and case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of North America brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure Growth Installed bAse and New Technology Penetration

The cardiac monitoring and cardiac rhythm management devices market also provides you with a detailed market analysis for every country's growth in healthcare expenditure for capital equipment, installed base of different kind of products for cardiac monitoring and cardiac rhythm management devices market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the cardiac monitoring and cardiac rhythm management devices market. The data is available for the historic period 2015-2020.

Competitive Landscape and North America Cardiac Monitoring and Cardiac Rhythm Management Devices Market Share Analysis

The cardiac monitoring and cardiac rhythm management devices market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to cardiac monitoring and cardiac rhythm management devices market.

Some of the major players operating in the cardiac monitoring and cardiac rhythm management devices market are:

• GENERAL ELECTRIC (U.S.)
• Abbott (U.S.)
• Boston Scientific Corporation (U.S.)
• SCHILLER (Switzerland)
• Koninklijke Philips N.V. (Netherlands)
• Biotronik SE & Co., KG (Germany)
• Hill-Rom Services, Inc. (U.S.)
• ABIOMED (U.S.)
• NIHON KOHDEN CORPORATION (Japan)
• ReliantHeart Inc. (U.S.)
• 3M (U.S.)
• Berlin Heart (Germany)
• Jarvik Heart, Inc. (U.S.)
• Stryker (U.S.)
• 아사히카세이(일본)
• 리바노바 PLC(영국)
• A BioTelemetry, Inc. (미국)
• OSI Systems, Inc. (미국)
• 미드마크 코퍼레이션(미국)
• ZOLL Medical Corporation (미국)
• 에드워즈 라이프사이언스 코퍼레이션(미국)
• 게티미그 AB(스웨덴)

SKU-1850